Ido Laskov - Concepedia

Author

Ido Laskov

Tel Aviv Sourasky Medical Center ORCID

Also Known As

I Laskov, I. D. Laskov, I. Laskov, Ido Laskov

121

Publications

898

Citations

H-Index

Concepts

All Affiliations

Tel Aviv Sourasky Medical Center Tel Aviv University McGill University Jewish General Hospital Rabin Medical Center

About

Ido Laskov is an author at Tel Aviv Sourasky Medical Center specializing in medicine, obstetrics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	228
2	Public Health	2	2	28
3	Cell Biology	1	1	13
4	Family Medicine	1	1	11
5	Immunology	1	1	13

Ido Laskov

Publications

736

Citations

H-Index

Page 1

	Year	Citations
Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer Ido Laskov, Laura M. Drudi, Marie‐Claude Beauchamp, Gynecologic Oncology Endocrine OncologyAnti-diabetic DosesMedicineGynecologyEndometrial Cancer	2014	103
Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors Charles‐André Philip, Ido Laskov, Marie‐Claude Beauchamp, BMC Cancer	2017	102
Outcome of singleton pregnancy in women ≥45 years old: a retrospective cohort study Ido Laskov, R. Birnbaum, Sharon Maslovitz, The Journal of Maternal-Fetal & Neonatal Medicine	2012	40
Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines Ido Laskov, Paul Abou-Nader, Oreekha Amin, International Journal of Gynecological Cancer	2016	35
The impact of <scp>COVID</scp>‐19 vaccine on sperm quality Shimi Barda, Ido Laskov, Dan Grisaru, International Journal of Gynecology & Obstetrics	2022	35
Maternal and neonatal outcome of pregnant women infected with H1N1 influenza virus (Swine Flu) Nadav Michaan, Sagi Amzallag, Ido Laskov, The Journal of Maternal-Fetal & Neonatal Medicine	2011	31
Clinical outcome of neoadjuvant chemotherapy for advanced ovarian cancer Roy Kessous, Ido Laskov, Jeremie Abitbol, Gynecologic Oncology MedicineCancer ManagementGynecologyCancer TreatmentOncology	2016	30
Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensitizes cancer cells to PARP inhibitors Oreekha Amin, Marie‐Claude Beauchamp, Paul Abou Nader, BMC Cancer	2015	29
CA‐125 reduction during neoadjuvant chemotherapy is associated with success of cytoreductive surgery and outcome of patients with advanced high‐grade ovarian cancer Roy Kessous, Michel D. Wissing, Sabrina Piedimonte, Acta Obstetricia Et Gynecologica Scandinavica	2020	27
Artemisone demonstrates synergistic antiviral activity in combination with approved and experimental drugs active against human cytomegalovirus Esther Oiknine‐Djian, Shikma Bar-On, Ido Laskov, Antiviral Research	2019	26

Page 1